Nanoform included in Nasdaq First North 25 index as of Jan 4th, 2021
Helsinki, Finland – Nasdaq announced today the results of the…
First dosing of nanoformed drug successfully accomplished
Press Release Nanoform Finland Plc December 21st, 2020 at 09.00…
Notification of major shareholdings according to Nanoform’s Articles of Association
PRESS RELEASE Nanoform Finland Plc December 8th, 2020 06.05 p.m.…
Nanoform makes US TV debut in Advancements with Ted Danson (CNBC)
PRESS RELEASE Nanoform Finland Plc December 2nd, 2020 4 p.m.…
Invitation to presentation of Nanoform’s Q3 Report on November 27
PRESS RELEASE Nanoform Finland Plc November 16, 2020 11:00 a.m.…
Nanoform to present at Avanza Börsdag on November 18
PRESS RELEASE Nanoform Finland Plc November 11th, 2020 11:00 a.m.…
Nanoform expands global commercial team with US appointments
Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle…
Nanoform’s positive commercial momentum continues
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.
Nanoform Finland Plc appoints Peter Hänninen as General Counsel
Press Release June 15, 2020 at 8:00 a.m. Finnish time…
Nanoform awarded GMP certification
Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine…
Nanoform appoints Miguel Calado as Chairman of the Board
Nanoform has appointed Miguel Calado as Chairman of the Board.
A message from Nanoform regarding COVID-19
The COVID-19 pandemic is evolving rapidly, and we would like to assure our customers, partners, and suppliers that we are diligently monitoring the situation and follow the most up-to-date World Health Organization, EU, and local government guidelines.
Nanoform and Orion collaborate on next-generation drug development
Nanoform and Orion Corporation, a Finnish pharmaceutical company, today announced a collaboration to apply Nanoform’s award-winning CESS® technology to new chemical entities.
Nanoform establishes US subsidiary
Nanoform has established Nanoform USA Inc., a wholly owned subsidiary in the US.
